Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07745712

Clinical Investigation to Validate the Safety and Performance of the ABLE Kids Device in Pediatric Patients With Neurological Gait Disorders in a Clinical Setting

The primary objective of the study is to validate the safety and clinical performance of the ABLE Kids device in pediatric patients with neurological gait disorders or muscular weakness during a 10-session gait training program in a clinical setting.

The secondary objective of the study focuses on obtaining preliminary data on the potential clinical and psychosocial benefits of the product.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

This is a pre-post, single-center, quasi-experimental study with an estimated duration of 17 weeks. The study will be conducted at Som·hi where a minimum of 10 evaluable participants are expected to be recruited within a period of 11 weeks.

After obtaining informed consent, through the Patient Information Sheet and the Informed Consent Form, the selection of the participants will be carried out to determine their inclusion in the study. Subjects who do not meet all the inclusion and exclusion criteria during the screening visit will be excluded from the study. At the latest, one week after the screening visit, the participants will undergo a baseline assessment without the medical device.

Participants will undergo a 10-session training program with the ABLE Kids device for a maximum duration of 3 weeks. Sessions will be conducted 5 times per week. Each session will last approximately 60 minutes. During the training period, session data will be taken to assess the safety and clinical performance of the device. At the latest, one week after the last training session, a post-training assessment will be performed. Finally, two weeks after the last training session, a follow-up assessment will be made to the participants via a telephone call to review any adverse events (AE) reported between the end of the training and the follow-up.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Minors with gait impairments, ranging from mild to severe, resulting from neurological conditions or muscular weakness
  • Anthropometric measurements compatible with the use of the exoskeleton, particularly:
  • Weight under 75 kg
  • Height between 1.0-1.5 m
  • Hip: maximum distance between greater trochanters of 35 cm
  • Thigh: maximum distance from trochanter to knee joint line of 36 cm
  • Lower leg: maximum distance from knee joint line to shoe sole of 45 cm
  • Medically stable
  • Intact skin in areas in contact with the device
  • Favorable medical assessment for standing, gait training, and weight-bearing activities
  • Signed informed consent from parents or legal guardians, and assent from the minor whenever possible, according to age and cognitive ability

Exclusion criteria

  • Severe spasticity in the lower limbs (MAS > 3)
  • Severe osteoporosis resulting in atraumatic bone fractures
  • Unhealed fractures or history of fragility fractures in the lower extremities within the past 2 years
  • Unstable or painful hip dislocation (MP > 50)
  • Symptomatic heterotopic ossification with mechanical limitation or pain
  • Anatomical limitations incompatible with proper fitting and safe use of the device:
  • Leg length discrepancy >1.5 cm in the upper segment or >2.0 cm in the lower segment
  • Severe scoliosis (Cobb angle >40° without the possibility of orthotic use during operation)
  • Inability to achieve proper adjustment within the device
  • Joint range of motion limitations preventing use of the exoskeleton:
  • Knee flexion contracture ≥40°
  • Hip flexion contracture ≥20°
  • Rigid equinus foot
  • Spine or lower extremity surgery within the last 3 months
  • Recently implanted pacemakers
  • Inability to communicate pain, fear, or discomfort (verbally or nonverbally)
  • Daytime mechanical ventilation
  • Uncontrolled epileptic seizures
  • Medical or cardiovascular instability
  • Considered unsuitable by physicians and physiotherapists. Any acute medical condition such as fever, infection, respiratory problems, urinary symptoms, uncontrolled pain, new swelling or redness in the extremities, active deep vein thrombosis, or severe comorbidities considered incompatible with the use of ABLE Kids until clinical resolution
  • Absence of head or trunk control in sitting or standing that cannot be compensated through the use of orthotic support during exoskeleton use

Treatment and study plan

ABLE Kids

Device

Participants will undergo a 10-session gait training program with the exoskeleton, five times a week for up to 3 weeks. Each session will last 60 minutes.

Primary outcomes

  1. Number and type of device-related Adverse Events

    Time frame: From baseline to follow-up (up to 2 weeks after end of intervention)

    To assess safety, the number of Severe Adverse Events (SAE), Adverse Events (AE) and drop-outs due to the device will be assessed and reported.

  2. Time taken to don/doff the device

    Time frame: Up to 3 weeks

    he time taken to don/doff the device will be measured in every session. Time will be measured in minutes and seconds for each activity. Donning time will start from the moment the participant is ready to transfer into the device until all the straps and clips are correctly tightened. Doffing time will start from the moment the participant starts taking off the device until they have completely removed it.

  3. Number of steps walked

    Time frame: Up to 6 weeks

    In each gait training session, the number of steps taken (step count) with the device will be automatically measured and registered by the device

  4. Distance walked

    Time frame: Up to 6 weeks

    In each gait training session, the distance walked (in meters) with the device will be automatically measured and registered by the device

  5. Time spent upright and time spent walking

    Time frame: Up to 6 weeks

    n each gait training session, the time spent upright (in minutes) and the time spent walking (in minutes) with the device will be automatically measured and registered by the device

  6. Number of people assisting the session

    Time frame: Up to 6 weeks

    In each gait training session, the number of people assisting will be recorded

Secondary outcomes

  1. Lower extremity muscle strenght

    Time frame: At baseline (day 0) and post-training (up to 4 weeks)

    The Daniels Muscle Testing scale will be used to measure the strength of muscles in the lower extremities. Scores range from 0 (absence of muscle activity) to 5 (normal muscle activity)

  2. Gross Motor Function Measure-88

    Time frame: At baseline (day 0) and post-training (up to 4 weeks)

    The Gross Motor Function Measure-88 (GMFM-88) is a standardized observational instrument designed to assess changes in gross motor function in children with motor impairments. It consists of 88 items grouped into five dimensions: lying and rolling, sitting, crawling and kneeling, standing, and walking/running/jumping. Each item is scored on a 4-point ordinal scale, with higher scores indicating better gross motor performance.

  3. Motor Function Measure-20

    Time frame: At baseline (day 0) and post-training (up to 4 weeks)

    The Motor Function Measure-20 (MFM-20) is a validated scale used to assess motor function in children with neuromuscular disorders. It evaluates functional abilities across three domains: standing position and transfers, axial and proximal motor function, and distal motor function. The scale consists of 20 items scored on a 4-point ordinal scale, with higher scores reflecting better motor performance.

  4. 10-Meter Walking Test (10MWT)

    Time frame: At baseline(day 0) and post-training (up to 4 weeks)

    The 10-Meter Walking Test (10MWT) test measures the time a person needs to walk 10 meters. This test will be performed in the pre-post evaluations without the device to assess the change in the walking function after the training.

  5. 2-Minute Walking Test (2MWT)

    Time frame: At baseline(day 0) and post-training (up to 4 weeks)

    The 2-Minute Walk Test (2MWT) measures the distance a person can walk in 2 minutes. This test will be assessed at baseline and at the end of the gait training program without the device to assess the change in the walking function after the training

  6. Modified Ashworth Scale (MAS)

    Time frame: At selection, baseline and post-training (up to 4 weeks)

    The Modified Ashworth Scale (MAS) measures spasticity in patients with lesions to the central nervous system. The scale assigns a grade of spasticity from 0 (no increase in muscle tone) to 4 (affected part rigid in flexion or extension).

  7. Pediatric Balance Score (PBS)

    Time frame: At baseline and post-training (up to 4 weeks)

    The Pediatric Balance Scale (PBS) is a standardized clinical assessment used to evaluate functional balance in children. Adapted from the Berg Balance Scale, it consists of 14 tasks commonly performed in everyday activities, such as sitting, standing, reaching, turning, and transferring. Each item is scored on a 5-point scale from 0 to 4, with higher scores indicating better balance performance.

  8. Location and level of pain - Face Pain Scale-Revised

    Time frame: From baseline to post-training (up to 4 weeks)

    The Faces Pain Scale-Revised (FPS-R) is a self-report instrument used to assess pain intensity in children. The scale presents a series of faces representing increasing levels of pain intensity, allowing participants to select the face that best matches their pain experience. Pain location is additionally recorded based on the participant's report. Higher scores indicate greater pain intensity.

  9. OMNI Rating of Perceived Exertion

    Time frame: rom baseline to post-training (up to 4 weeks)

    The OMNI Rating of Perceived Exertion Scale is a validated self-report measure used to assess perceived physical effort during exercise in pediatric populations. The scale combines numerical ratings with verbal descriptors and pictorial representations to help children quantify their level of exertion during physical activity. Higher scores indicate greater perceived exertion.

  10. Functional Independence Measure For Children (WeeFIM)

    Time frame: At baseline and post-training (up to 4 weeks)

    The Functional Independence Measure for Children (WeeFIM) is a standardized instrument used to assess functional independence in children. It evaluates performance in self-care, mobility, and cognition through 18 items scored on a 7-level scale, where 1 indicates total assistance and 7 indicates complete independence. Higher scores reflect greater functional independence in activities of daily living.

  11. Self-perceived impact on general health status

    Time frame: At post-training (up to 4 weeks)

    Participants' perceptions of the impact on their general health will be evaluated by the completion of a self-report questionnaire on the perceived impact on general health. This questionnaire has been designed by the researchers and intends to identify to what extent participants feel that the ABLE Exoskeleton contributed to a change in their health. The questionnaire covers 7 categories (cardiovascular system, musculoskeletal pain, neuropathic pain, bladder and bowel, spasticity, and sleep quality) using a 7-point Likert scale to assess the change.

  12. Quebec User Evaluation of Satisfaction with assistive Technology (QUEST 2.0) score

    Time frame: At post-training (up to 4 weeks)

    The Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) is a 12-item outcome measure that assesses user satisfaction with two components (Device and Services) using a 5-point scale ranging from 1 (not satisfied) to 5 (very satisfied). Only the 8 items referred to the device will be evaluated from participants and the whole 12 items from the therapists to measure user satisfaction with the ABLE Exoskeleton after the training program experience

  13. EuroQol 5 Dimensions Youth - 5 Levels (EQ-5D-Y-5L)

    Time frame: At baseline and post-training (up to 4 weeks)

    The EQ-5D-Y-5L is a standardized self-reported instrument used to assess health-related quality of life in children and adolescents. It evaluates five dimensions: mobility, looking after myself, doing usual activities, having pain or discomfort, and feeling worried, sad, or unhappy. Each dimension is rated on a 5-level scale ranging from "no problems" to "extreme problems." The instrument also includes a visual analogue scale (EQ VAS) for the participant's overall perception of their health status.

Study contacts

Contact information is provided by the study sponsor or research team.

Nuria Maspoch Clemente

CONTACT

[email protected]

+34 634 64 34 96

Sponsors and collaborators

Lead sponsor

ABLE Human Motion S.L.

Industry

Collaborators

  • Som·hi Rehab

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Aug 4, 2026
Registry last updated
Aug 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.